Takeda Stresses Orexin Commitment Despite Setback

Big Share Buyback As Q2 Reported

 
• By Ian Haydock
narcolepsy
Takeda looks to hold up orexin franchise after recent trial halt • Source: Alamy

More from Earnings

More from Business